JP2024519140A5 - - Google Patents
Info
- Publication number
- JP2024519140A5 JP2024519140A5 JP2023572596A JP2023572596A JP2024519140A5 JP 2024519140 A5 JP2024519140 A5 JP 2024519140A5 JP 2023572596 A JP2023572596 A JP 2023572596A JP 2023572596 A JP2023572596 A JP 2023572596A JP 2024519140 A5 JP2024519140 A5 JP 2024519140A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163194138P | 2021-05-27 | 2021-05-27 | |
| US63/194,138 | 2021-05-27 | ||
| US202163203667P | 2021-07-27 | 2021-07-27 | |
| US63/203,667 | 2021-07-27 | ||
| US202163290587P | 2021-12-16 | 2021-12-16 | |
| US63/290,587 | 2021-12-16 | ||
| PCT/CA2022/050864 WO2022246576A1 (en) | 2021-05-27 | 2022-05-27 | Camptothecin analogues, conjugates and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024519140A JP2024519140A (ja) | 2024-05-08 |
| JP2024519140A5 true JP2024519140A5 (https=) | 2025-08-01 |
| JPWO2022246576A5 JPWO2022246576A5 (https=) | 2025-08-01 |
Family
ID=84229147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572596A Pending JP2024519140A (ja) | 2021-05-27 | 2022-05-27 | カンプトテシン類似体、複合体及び使用の方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240269309A1 (https=) |
| EP (1) | EP4347601A4 (https=) |
| JP (1) | JP2024519140A (https=) |
| KR (1) | KR20240031235A (https=) |
| AU (1) | AU2022282813A1 (https=) |
| BR (1) | BR112023024433A2 (https=) |
| CA (1) | CA3177067A1 (https=) |
| IL (1) | IL308734A (https=) |
| MX (1) | MX2023013738A (https=) |
| WO (1) | WO2022246576A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022238571A1 (en) | 2021-03-18 | 2023-09-14 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| CA3228345A1 (en) * | 2021-08-19 | 2023-02-23 | Zhen Li | Camptothecin derivative, and pharmaceutical composition and use thereof |
| CN118414339A (zh) * | 2021-12-16 | 2024-07-30 | 迈威(上海)生物科技股份有限公司 | 一种喜树碱类化合物及其偶联物 |
| IL315508A (en) * | 2022-03-17 | 2024-11-01 | Seagen Inc | Camptothecin conjugates |
| IL315393A (en) * | 2022-03-25 | 2024-11-01 | Zymeworks Bc Inc | Antibody preparations for drugs targeting alpha acid receptor and methods of use |
| EP4524140A1 (en) * | 2022-05-13 | 2025-03-19 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Camptothecin compound, preparation method therefor and use thereof |
| CN116675727A (zh) * | 2022-12-28 | 2023-09-01 | 广州医科大学 | 一种以不保护氨基酸为氨组分合成酰胺和/或多肽的方法 |
| CN117281809A (zh) * | 2023-03-09 | 2023-12-26 | 兰州大学 | 喜树碱类衍生物在制备治疗膀胱癌药物中的应用 |
| EP4720075A1 (en) * | 2023-05-26 | 2026-04-08 | NJ Bio, Inc. | Topoisomerase inhibitors, methods of making, and methods of use thereof |
| WO2024255740A1 (zh) * | 2023-06-13 | 2024-12-19 | 成都倍特药业股份有限公司 | 用于治疗或预防癌症的喜树碱衍生物及其抗体药物偶联物 |
| WO2025078841A2 (en) | 2023-10-11 | 2025-04-17 | Antikor Biopharma Limited | Antibodies, conjugates, and uses thereof |
| WO2025080693A1 (en) * | 2023-10-11 | 2025-04-17 | Minerva Biotechnologies Corporation | Anti-muc1* antibody drug complexes and uses thereof |
| TW202530268A (zh) * | 2023-10-19 | 2025-08-01 | 加拿大商酵活英屬哥倫比亞有限公司 | 抗ｎａｐｉ２ｂ抗體－藥物結合物及使用方法 |
| WO2025235686A1 (en) * | 2024-05-07 | 2025-11-13 | Aarvik Therapeutics, Inc. | Fluorocamptothecin compounds, conjugates, and methods thereof |
| KR20250170534A (ko) * | 2024-05-28 | 2025-12-05 | 한미약품 주식회사 | 항종양 활성을 지니는 신규한 설파마이드 캄토테신 유도체 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136978A (en) * | 1993-06-30 | 2000-10-24 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
| JP2002255821A (ja) * | 2001-03-06 | 2002-09-11 | Yakult Honsha Co Ltd | 抗癌剤耐性癌に対する治療剤 |
| AU2018237683A1 (en) * | 2017-03-24 | 2019-10-31 | Seagen Inc. | Process for the preparation of glucuronide drug-linkers and intermediates thereof |
| JP7561141B2 (ja) * | 2019-04-26 | 2024-10-03 | イミュノジェン・インコーポレーテッド | カンプトテシン誘導体 |
| CN110128501A (zh) * | 2019-05-21 | 2019-08-16 | 北京海美源医药科技有限公司 | 一种靶向fap酶的喜树碱类化合物及其制备方法和应用 |
| IL299001A (en) * | 2020-06-19 | 2023-02-01 | Hangzhou Dac Biotech Co Ltd | Pairings of a cell-binding molecule with camptocin analogs |
| MX2023008895A (es) * | 2021-02-09 | 2023-08-09 | Medilink Therapeutics Suzhou Co Ltd | Conjugado de sustancia bioactiva, metodo de preparacion y uso del mismo. |
| MX2023010819A (es) * | 2021-03-18 | 2023-09-28 | Seagen Inc | Liberacion selectiva de farmacos a partir de conjugados internalizados de compuestos biologicamente activos. |
| CN117980327A (zh) * | 2021-11-03 | 2024-05-03 | 杭州多禧生物科技有限公司 | 抗体的特异性偶联 |
-
2022
- 2022-05-27 IL IL308734A patent/IL308734A/en unknown
- 2022-05-27 KR KR1020237044336A patent/KR20240031235A/ko active Pending
- 2022-05-27 JP JP2023572596A patent/JP2024519140A/ja active Pending
- 2022-05-27 MX MX2023013738A patent/MX2023013738A/es unknown
- 2022-05-27 AU AU2022282813A patent/AU2022282813A1/en active Pending
- 2022-05-27 BR BR112023024433A patent/BR112023024433A2/pt unknown
- 2022-05-27 EP EP22810026.9A patent/EP4347601A4/en active Pending
- 2022-05-27 US US18/562,049 patent/US20240269309A1/en active Pending
- 2022-05-27 CA CA3177067A patent/CA3177067A1/en active Pending
- 2022-05-27 WO PCT/CA2022/050864 patent/WO2022246576A1/en not_active Ceased